CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM NEW
Total 13F shares
4,279,391
Share change
+788,537
Total reported value
$78,484,295
Put/Call ratio
238%
Price per share
$18.34
Number of holders
69
Value change
+$15,168,259
Number of buys
44
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q3 2020

As of 30 Sep 2020, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,279,391 shares. The largest 10 holders included BlackRock Inc., Man Group plc, Candriam Luxembourg S.C.A., HILLHOUSE CAPITAL ADVISORS, LTD., STATE STREET CORP, VANGUARD GROUP INC, NORTHERN TRUST CORP, GLAZER CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Qube Research & Technologies Ltd. This page lists 69 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.